Feasibility of Induction Docetaxel, Cisplatin, 5-Fluorouracil, Cetuximab (TPF-C) Followed by Concurrent Cetuximab Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

Feasibility of Induction Docetaxel, Cisplatin, 5-Fluorouracil, Cetuximab (TPF-C) Followed by Concurrent Cetuximab Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

Purpose: To report our experience with a sequential regimen of induction TPF-C followed by radioimmunotherapy with cetuximab in patients with locally advanced head and neck squamous cell carcinoma (HNSCC).

Bibliographic Details
Main Authors: Charalambakis, Nikolaos, Kouloulias, Vassilis, Vaja, Helena, Pectasides, Dimitrios, Rampias, Theodoros, Economopoulos, Theofanis, Katsaounis, Panagiotis, Siolos, Spiros, Bartzi, Valentina, Perisanidis, Christos, Laschos, Konstantinos, Maragoudakis, Pavlos, Proikas, Konstantinos, Papadimitriou, Nikolaos, Papadogeorgakis, Nikolaos, Georgopoulou, Helen, Zygogianni, Anna, Artopoulou, Ioli, Pappa, Eleni, Dimitriadis, George, Psyrri, Amanda
Format: Online
Language:English
Published: Frontiers Media S.A. 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557442/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557442/

Similar Items